1st Quarter - Report

SOCIETY FOR MATERNAL-FETAL MEDICINE for SOCIETY FOR MATERNAL-FETAL MEDICINE

Firm
Client
Income
—
Expenses
$20,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY20 Labor-Health and Human Services-Education approporiations/maternal and infant health/AHRQ/NIH/CDC/HRSA

LobbyistCovered position, as disclosed
KATHRYN SCHUBERT —

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Health Issues HCR

S. 916/HR 1897 MOMMA's Act (maternal mortality); S. 116 MOMS Act (maternal health); maternal mortality, severe maternal morbidity, research in pregnancy

LobbyistCovered position, as disclosed
KATHRYN SCHUBERT —

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA)

Bills named: S. 916 (116th), S. 116 (116th), H.R. 1897 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.